Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study

Autor:	Palumbo, Antonio, Cavallo, Federica, Hardan, I, Lupo, B, Redoglia, V, Levin, M, Corradini, P, Pezzatti, S, Patriarca, F, Cavo, M, Marcatti, M, Pescosta, N, Falcone, Ap, Ria, R, Rossi, D, Benevolo, G, Cangialosi, C, Galli, M, Catalano, L, Baraldi, A, Carella, Am, Cafro, A, Siniscalchi, A, Crippa, C, Grammatico, S, Cavalli, M, Caravita Di Toritto, T, Di Raimondo, F, Nagler, A, Boccadoro, Mario
Jazyk:	angličtina
Rok vydání:	2011
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od_______970::a1928c06f7b702c931b8f09b0c34d1f6 http://hdl.handle.net/2318/118592 Zobrazit plný text záznamu